|
|
||||
PD-0104: Testing All Claimed Platforms |
||||
|
This decision represents a long-term technical decision based on an OD, and may not be the same as the final results of the source OD. With respect to published criteria documentation and scheme documents, it provides suggested guidance on evaluation direction, but is not authoritative. Authoritative decisions are provided through the published criteria documents and published scheme and international interpretations thereof. With respect to published PPs, PDs are authoritative corrections to the PP, based on input from the PP author (if available), that are in force until the publication of the next revision of that PP.
IssueAssume a TOE runs on multiple platforms, where each platform is a layered abstract machine such that the TOE has no dependencies on any layer except the uppermost layer. Is it acceptable to select test configurations based solely on variances in the upper most layer of the abstract machine? ResolutionAs discussed in PD-0084, claiming that a TOE runs in multiple IT environments does not require that the TOE be tested with each environment, although this would be acceptable. If the testers wish to limit the scope of testing, they may either:
In both of the above cases, the certificate, VR, and VPL entry will clearly state what was tested. Any platform that is not tested or covered by a rationale is not to be included in the evaluated configuration. Any SFRs that are provided by the platform are not to be credited to the TOE. Also, the IGS procedures detail the secure installation of the TOE; therefore, if there are settings, configuration options, etc of the platform(s) that will affect the installation of the TOE, they must be included, as would any other part of the environment that affects installation. SupportIt is recognized that risk of missing security critical issues is increased by not testing with each environment with which the ST claims the TOE is compatible. Yet this is symptomatic of the CC paradigm and is addressed by (1) accepting the risk and making it explicit via "truth in advertising" on the CC certificate and care in the presentation of evaluation results or (2) by the ST author changing the definition of the TOE to reduce the risk. It is not be addressed by enlarging the scope of the evaluation activities. Modification History:
References:
Related NIs:
Related CCIMB-INTERPs:
Source OD: 0228 |